Clinical Trials Directory

Trials / Completed

CompletedNCT04164355

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg

Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days: a Single-centre Prospective-control

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Federico II University · Academic / Other
Sex
Male
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.

Detailed description

Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood flow to the penis thus promoting the erection. This drug represents an treatment for erectile dysfunction in patients after radical prostatectomy. The optical coherence tomography angiography represents a novel and non-invasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features. The study evaluates the changes in optical coherence tomography angiography parameters at baseline and after 1, 3, 6 months after the somministration of Tadalafil 20 mg orally.

Conditions

Interventions

TypeNameDescription
DRUGTadalafil 20 MGTo study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, at baseline and 1, 3, 6 months after radical prostatectomy

Timeline

Start date
2020-07-04
Primary completion
2021-04-25
Completion
2021-04-30
First posted
2019-11-15
Last updated
2021-09-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04164355. Inclusion in this directory is not an endorsement.